Source: BMC Structural Biology. Unidade: IFSC
Subjects: DOENÇA DE ALZHEIMER, MUTAÇÃO GENÉTICA, DNA
ABNT
VALADARES, Napoleão F. et al. Molecular determinants of improved cathepsin B inhibition by new cystatins obtained by DNA shuffling. BMC Structural Biology, v. 10, p. 30-1-30-9, 2010Tradução . . Disponível em: https://doi.org/10.1186/1472-6807-10-30. Acesso em: 25 out. 2025.APA
Valadares, N. F., Dellamano, M., Costa, A. S., Silva, F. H., & Garratt, R. C. (2010). Molecular determinants of improved cathepsin B inhibition by new cystatins obtained by DNA shuffling. BMC Structural Biology, 10, 30-1-30-9. doi:10.1186/1472-6807-10-30NLM
Valadares NF, Dellamano M, Costa AS, Silva FH, Garratt RC. Molecular determinants of improved cathepsin B inhibition by new cystatins obtained by DNA shuffling [Internet]. BMC Structural Biology. 2010 ; 10 30-1-30-9.[citado 2025 out. 25 ] Available from: https://doi.org/10.1186/1472-6807-10-30Vancouver
Valadares NF, Dellamano M, Costa AS, Silva FH, Garratt RC. Molecular determinants of improved cathepsin B inhibition by new cystatins obtained by DNA shuffling [Internet]. BMC Structural Biology. 2010 ; 10 30-1-30-9.[citado 2025 out. 25 ] Available from: https://doi.org/10.1186/1472-6807-10-30
